Epithelial Malignancies的临床试验
总计22454个结果
-
University of KentuckyArno Therapeutics完全的
-
Novartis Pharmaceuticals终止
-
Sigma-Tau Research, Inc.Dana-Farber Cancer Institute; Rhode Island Hospital完全的
-
Heidelberg Pharma AGUnited States Department of Defense完全的
-
Incyte Corporation完全的
-
Millennium Pharmaceuticals, Inc.完全的
-
Millennium Pharmaceuticals, Inc.完全的
-
First Affiliated Hospital Xi'an Jiaotong UniversityEureka Therapeutics Inc.未知
-
Samyang Biopharmaceuticals Corporation完全的
-
Washington University School of Medicine完全的
-
Millennium Pharmaceuticals, Inc.撤销
-
Mayo ClinicGlaxoSmithKline完全的
-
Cooperative Study Group A for Hematology完全的
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., Belgium完全的药代动力学 | 晚期恶性肿瘤 | 实体恶性肿瘤 | 蛋白激酶抑制剂 | 最大耐受剂量 | 抗肿瘤方案 | 临床试验,第一阶段
-
Medical College of Wisconsin完全的Malignancies, Hematologic美国
-
M.D. Anderson Cancer Center尚未招聘
-
Shanghai Escugen Biotechnology Co., LtdEscugen (Australia) Biotechnology Pty Ltd尚未招聘B 细胞淋巴恶性肿瘤
-
Shanghai Junshi Bioscience Co., Ltd.CTI Clinical Trial and Consulting Services; TopAlliance Biosciences, Inc.撤销恶性肿瘤 | 以前治疗过,高级
-
Eisai Inc.完全的
-
M.D. Anderson Cancer CenterReata Pharmaceuticals, Inc.完全的
-
First Affiliated Hospital of Fujian Medical University招聘中